NCT07666178 Continuous ESP Block in Patients Undergoing CABG Surgery.
| NCT ID | NCT07666178 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Instituto do Coracao |
| Condition | Erector Spinae Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 78 participants |
| Start Date | 2024-12-12 |
| Primary Completion | 2027-12-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 78 participants in total. It began in 2024-12-12 with a primary completion date of 2027-12-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study addresses articles and studies related to the erector spinae plane (ESP) block and its technique, advantages and disadvantages, applicability, among others. It aims to provide more information about this block, which is relatively new, and how it can be explored in the anesthesiologist's routine, mainly inserted in the anesthesia scenario for cardiac surgery with a focus on postoperative analgesia.
Eligibility Criteria
Inclusion Criteria: * Consent to the free and informed consent term. * Patient undergoing coronary artery bypass graft surgery with cardiopulmonary bypass (CPB). * Preserved left ventricular global function (LVEF \> 50%). Exclusion Criteria: * Moderate or severe valvular dysfunction. * Previous anterior sternotomy. * Known allergy to the study drugs. * Complications during catheter insertion or block placement. * Pre-existing diagnosed chronic pain under treatment. * Concomitant use of drugs with a long half-life (induction and anesthetic maintenance doses will be standardized; patients taking medications with a long half-life are excluded to prevent bias in outcome assessment). * Concomitant administration of Magnesium Sulfate.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07666178 clinical trial?
This trial is open to participants of all sexes, studying Erector Spinae Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07666178 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 78 participants.
Is NCT07666178 currently recruiting?
Yes, NCT07666178 is actively recruiting participants. Contact the research team at joaoalbertopastor@yahoo.com.br for enrollment information.
Where is the NCT07666178 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07666178 clinical trial?
NCT07666178 is sponsored by Instituto do Coracao. The trial plans to enroll 78 participants.